Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate Update
April 30 2024 - 8:00AM
Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global
pharmaceutical company whose mission is to be invaluable to
patients, physicians and partners concerned with retinal health and
maintaining better vision longer, announces today that it will
report first quarter financial results on May 14, 2024, prior to
the market open.
Management will host a conference call at 9:00 AM
ET on the same day, to review financial results and provide an
update on corporate developments. Following management’s formal
remarks there will be a question-and-answer session.
Participants can register for the conference by
navigating to
https://dpregister.com/sreg/10188147/fc37036c2f
Please note that registered participants will
receive their dial-in number upon registration and will dial
directly into the call without delay. Those without internet access
or who are unable to pre-register may dial in by calling
1-844-839-2190 (domestic) or 1-412-717-9583 (international). All
callers should dial in approximately 10 minutes prior to the
scheduled start time and ask to be joined into the Alimera Sciences
call.
The conference call will also be available through
live webcast
at https://event.choruscall.com/mediaframe/webcast.html?webcastid=rPb7Xp5V and
is also available through the company’s website.
A webcast replay of the call will be available
approximately one hour after the end of the call through August 14,
2024. The webcast replay can be accessed through the above links or
by calling 1-877-344-7529 (domestic) or 1-412-317-0088 (toll) or
via an international dial-in number at:
https://services.choruscall.com/ccforms/replay.html. Please use the
following replay code 9720210. The telephonic replay will be
available until May 28, 2024.
About Alimera Sciences,
Inc.Alimera Sciences is a global pharmaceutical company
whose mission is to be invaluable to patients, physicians and
partners concerned with retinal health and maintaining better
vision longer. For more information, please visit
www.alimerasciences.com.
For press inquiries: |
For investor inquiries: |
Jules Abraham |
Scott Gordon |
for Alimera Sciences |
for Alimera Sciences |
917-885-7378 |
scottg@coreir.com |
julesa@coreir.com |
|
Alimera Sciences (NASDAQ:ALIM)
Historical Stock Chart
From Apr 2024 to May 2024
Alimera Sciences (NASDAQ:ALIM)
Historical Stock Chart
From May 2023 to May 2024